Abstract:In China, recent years have witnessed significant growth in the pharmaceutical industry and an acceleration in pharmaceutical innovation. As a knowledge-intensive sector, the growth of the pharmaceutical industry in China marks an increasing need for protecting the enormous amounts of money invested in research and development. Arguably, the most efficient way for industry actors to recover their investments is through granting a limited duration of exclusive IP rights for the use and production of their products. Against this backdrop, over the past decades, China has adopted a series of IP-related laws and regulatory policies in China. On this basis, corporate demands and legislative efforts in China have led us to believe that a sound IP system that is compatible with China's development needs would necessarily help stimulate investment, facilitate technology transfer, and more importantly, allocate the rights and benefits over knowledge and resources among various stakeholders. This is because, at first sight, the IP rights approach contains an obvious solution to the problem of misappropriation or free riding by addressing the problem of non-excludability of traditional medical knowledge (TMK) and associated genetic resources. However, the real picture couldn't be more complex and different. The analysis of this article finds that China's existing IP systems supply a conducive context for pharmaceutical corporations to exploit the system's full strategic potential in plundering TMK and associated genetic resources. This situation has placed local communities and other TMK holders in China at a disadvantage.

Research on the Protection of Intellectual Property and Sustainable Development in Medicine and Pharmaceutical in China

The Protection of Intellectual Property Rights: the Core Strategy for Global Development of Traditional Chinese Medical Industry in the 21st Century

Research on the Pharmaceutical Intellectual Property Protection and Supervision of Pharmacy Administration.

Research on the Protection Strategy of the Traditional Chinese Medicine Intellectual Property

Research on the Path to Breakthrough in the Dilemma of Chinese Traditional Medicine Intellectual Property Protection

Study on Sustainable China’s Pharmaceutical Innovation Ecosystem

Analysis of Protecting for Chinese Medical and Pharmaceutical Intellectual Property

On Accessibility and Patent Protection of Drugs

Discussion on the Intellectual Property Protection in the Drug Registration Regulations

Pharmaceutical corporate power, traditional medical knowledge, and intellectual property governance in China

Intellectual Property Tools in Safeguarding Intangible Cultural Heritage: A Chinese Perspective

On the intellectual property right protection of mongolian medicine

Protection for IP of Traditional Chinese Medicine from the Perpective of Imternational Law

An Overall Analysis of Judicial Protection for Drug Patent in China:Focus on Legislation and Juridical Practice

Research on the Protection of Intellectual Property Right of Traditional Medicines in India

Analysis of the Problems and Countermeasures of the Protection of Intellectual Property Rights in China

Progress of Modernization in Chinese Traditional Medicine and Patent Medicine

Current Situation and Future Development of Intellectual Property Protection in China

Striking A Balance Between Intellectual Property Protection of Traditional Chinese Medicine and Access to Knowledge

Institutional Construction of Sustainable Development of TCM Industry-Intellectual Property Right Protection and Standardization of TCM Suitable for " Research of Big Sciences"

Intellectual property protection for traditional medical knowledge in China’s context: a round peg in a square hole?